SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from APPLIED GENETIC TECHNOLOGIES CORP (CIK 0001273636) — Feb 5, 2020

APPLIED GENETIC TECHNOLOGIES CORP (CIK 0001273636)
Date: Feb. 5, 2020 · CIK: 0001273636 · Accession: 0001193125-20-025478

AI Filing Summary & Sentiment

File numbers found in text: 333-236156

Date
January 29, 2020
Author
WELLS FARGO SECURITIES, LLC
Form
CORRESP
Company
APPLIED GENETIC TECHNOLOGIES CORP (CIK 0001273636)

Letter

CORRESP (U/W Acceleration)

Wells Fargo Securities, LLC

500 West 33rd Street

New York, New York 10001

Wedbush Securities Inc.

1000 Wilshire Boulevard

Los Angeles, California 90017

February 5,

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C.

Attn: Ada D. Sarmento

Re:

Applied Genetic Technologies Corporation

Registration Statement on Form S-1

Originally Filed January 29, 2020

File No. 333-236156

Request for Acceleration of Effective Date

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Applied Genetic Technologies Corporation (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 PM, Eastern Time, on February 6, 2020, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Foley Hoag LLP, request by telephone that such Registration Statement be declared effective.

Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each Underwriter or dealer, who is reasonably anticipated to participated in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very truly yours,
WELLS FARGO SECURITIES, LLC

Show Raw Text
CORRESP
1
filename1.htm

CORRESP (U/W Acceleration)

 Wells Fargo Securities, LLC

500 West 33rd Street

 New York, New York 10001

Wedbush Securities Inc.

 1000 Wilshire Boulevard

Los Angeles, California 90017

 February 5,
2020

 Securities and Exchange Commission

 Division of
Corporation Finance

 100 F Street, N.E.

 Washington, D.C.
20549

 Attn: Ada D. Sarmento

Re:

 Applied Genetic Technologies Corporation

Registration Statement on Form S-1

Originally Filed January 29, 2020

 File No. 333-236156

Request for Acceleration of Effective Date

 Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several
underwriters, hereby join in the request of Applied Genetic Technologies Corporation (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 PM, Eastern
Time, on February 6, 2020, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Foley Hoag LLP, request by telephone that such Registration Statement be declared effective.

Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to
each Underwriter or dealer, who is reasonably anticipated to participated in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the
preliminary prospectus.

 We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have
been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very truly yours,

WELLS FARGO SECURITIES, LLC

WEDBUSH SECURITIES INC.

 Acting severally on behalf of themselves and the

several Underwriters

WELLS FARGO SECURITIES, LLC

By:

/s/ Geoff Goodman

Name: Geoff Goodman

Title: Managing Director

WEDBUSH SECURITIES INC.

By:

/s/ Ben Davey

Name: Ben Davey

Title: Managing Director